births,1 2 and the clinical presentation was the classical one with diarrhoea, low rate of weight gain, and malnutrition in children below the age of 2 years.
From the middle of the 1 970s, decreasing incidences were found in the UK-6 and Ireland7 and later also in Austria.8 In a study from Italy, Greco et al reported an unchanged incidence with a predominance of classical cases.9 From Tampere, Finland, a change from the classical presentation to one with mild and atypical signs and symptoms presenting at school age and in adolescence was reported.' 10 This resulted in a cumulative incidence of 0-12 per 1000 at 2-3 years of age, reaching 1 per 1000 in adolescence. tComparing the countries, p>0-05.
On the other hand, during the 1980s, a threefold increase in incidence to levels around 3-3 5 per 1000 live births, one of the highest figures reported, was found in Sweden, with the classical presentation still predominating." 12 This increase in incidence occurred during a period when feeding habits changed: breast feeding increased both in prevalence and duration, the introduction of gluten was delayed, and the amount of gluten consumed by infants possibly increased. 13 The disparate trends of coeliac disease in Sweden and Finland prompted us to make a joint study with the aim of establishing data on the observed differences in clinical expression and age distribution, and exploring potential causes of these differences, such as genetic factors and feeding habits.
Patients and methods

CLINICAL STUDY GROUPS
Cases of coeliac disease diagnosed between 1 January 1985 and 31 December 1989 in the paediatric departments in Tampere, Finland (Finnish patients) and Gothenburg, Sweden (Swedish patients) were included in the study ( At child health centres healthy 9 or 12 month old children were invited to a study on food ingestion. In Tampere, 107 children (60 at 9 months and 47 at 12 months) were recruited from one child health centre in the city and one in the countryside. In Gothenburg, all 33 children (20 at 9 months and 13 at 12 months) in the catchment area of two selected suburban child health centres, typical of middle and lower class areas, were studied. The study was carried out in 1990-1.
Another group also consisting of 33 children (20 at 9 months and 13 at 12 months) had been studied in Gothenburg in 1978 with the same method for recording of food intake. This group originally served as a control group in another study2l and was now used as a historical comparison group.
The recordings were made by the parents, after receiving instruction, and included all foods and beverages given measured with household measures. In Tampere, the recordings were made during the seven days before the child was 9 and 12 months old, respectively. In Gothenburg, they were made during four days around the age of 9 months (range 8-10) and 12 months (range [11] [12] [13] [14] .
The amount of gluten-containing cereals (wheat, rye, oats, and barley) was calculated by one paediatric dietitian in each centre. The methods applied for calculations were the same in the two study centres and were qualitatively ensured through coordination meetings. For home made foods, estimates of types and amounts of flour used were made from recipes in the most commonly used cookery books in each country and related to tables of energy and nutrient content issued by the National Food Administrations.22 23 For industrial products (powder for gruels and porridges), data from the manufacturers were used. The proportions of protein in each type of cereal used in the calculations were, according to the results of cereal analysis from the National Food Administrations in each country, 8-5 g, 8-2 g, 13-3 g, and 9-2 g per 100 g of wheat, rye, oats, and barley in Sweden22 and 9 9 g, 10-0 g, 12-5 g, and 9-2 g in Finland. analysis, and odds ratios with 95% confidence intervals were used where appropriate.
Results
CLINICAL STUDY
The age distribution at diagnosis showed considerable differences between the two centres (figure, table 1).
Signs and symptoms at the age of birth to 2 years, irrespective of age at diagnosis, were compared (table 2). The Finnish patients and patients with late diagnosis at both centres had significantly less severe symptoms at this age.
The classical presentation was seen in 3% of the Finnish patients, compared with 79°/O of the Swedish children (p<0 001). All of them were diagnosed before 2-5 years of age.
Signs and symptoms at diagnosis differed between the countries and age groups (table  3) . When controlling for the different age intervals, significant differences between the countries were found for abdominal distension (p=0001), constipation (p<005), and abnormal weight gain (p<0 05), all more frequent in the Swedish patients. Constipation often appeared in periods, altemating with periods of loose stools/diarrhoea. The group 'other symptoms' comprised menorrhagia with irregular periods (n= 1), gastro-oesophageal reflux (n= 1), enamel hypoplasia (n= 1), and brittle diabetes mellitus (n= 1) among the Finnish patients and recurrent fever (n=3), headache (n= 1), and exanthema (n= 1) among the Swedish patients. Among the Finnish patients, 12 (20%) had insulin dependent diabetes mellitus (IDDM) compared with two (2%) among the Swedish. While data on growth were routinely measured prospectively and depicted in growth charts, data on signs and symptoms relied on retrospective data, as recorded in documents. The risk of a systematic bias, especially when comparing two countries, must be considered. However, the health care systems in Finland and Sweden are very similar, as are also the general medical standards and practices. Further, the observed clinical differences are so huge, that it is highly unlikely they could be explained only as a bias effect.
What factors could then be associated with the differences in clinical expression and incidence? Family, twin, and HIA studies have all shown the existence of a genetic factor of importance for development of coeliac disease.24 Could this factor explain the differences?
In the second part of the study, a predominance of the HILA haplotypes Al, B8, DR3
were seen in patients in both study areas, with no significant difference between the case groups. These HLA groups were more common in the Swedish than in the Finnish reference group, and may be one determinant of the higher incidence/prevalence of coeliac disease in Sweden. Given the similar HLA set up in those with coeliac disease in both Sweden and Finland, it is unlikely that genetic differences explain the rapid change in clinical expression and increased incidence observed. A factor more likely to contribute to such changes is the infant feeding pattern. We therefore compared food ingestion between groups of healthy infants. Patients with coeliac disease often have anorexia as a dominant feature and retrospective food recall of coeliac disease patients from the time before the development of symptoms might be less valid and perhaps biased. Records of food ingestion have been found to be a valid method, and one, three, and seven day records have shown equivalent results.25
The duration of breast feeding in both Finland and Sweden was very short in the early 1970s. Since then it has increased continuously, both in the population and among infants who develop coeliac disease later.1 10 13 26 In Finland this coincided with the trend of later manifestations of symptoms among coeliacs. In Sweden, surprisingly, this was followed by, or coincided with, the strong increase in coeliac disease incidence. The most recent population figures indicate a breast feeding prevalence of 60-70% at 6 months in Finland and 500/o in Sweden. In this study, we found a significantly higher prevalence of breast feeding in Tampere in 9 month old infants compared with Gothenburg. The conclusion from a series of Italian studies was that extended breast feeding delays the development of clinical symptoms of coeliac disease.27-29 However, the divergent trends of Finland and Sweden indicate that factors other than breast feeding also influence the result.
The method for calculation of ingested cereal protein used in this study avoids the controversial question of toxicity of prolamines and the pertaining methodological issues.30 It also allows comparison between groups as there is a strong correlation between the amounts of protein and prolamine in cereals.
In Finland, the recommended age for gluten introduction has been 5 months since before 1970. In Sweden, it was changed from 4 to 6 months in 1983, and that recommendation was closely followed. The patients with coeliac disease did not differ in this aspect and although we had data on gluten introduction on only a fraction of the Finnish patients, previous studies have shown the same.1 13 Also in 1983, the amount of gluten in the industrially produced gruels and porridges in Sweden was doubled on average. '3 Infants in Gothenburg ingested two to three times more wheat protein than in Tampere. At 9 months of age they also consumed 50% more than in 1978, which was before the onset of the increase of incidence.
Some statistically significant differences of the amounts of rye, barley, and oats protein consumed between the countries and over time were found, although so small that they are probably without clinical importance.
In this study, we have used all accessible material to compare possible background factors of importance for the different development of coeliac disease. Although the design of our study does not permit firm conclusions, it indicates that the amount of wheat protein consumed in infancy might be one factor of importance for the clinical expression of coeliac disease. What does that imply? One possibility is that the ingestion of high amounts of wheat protein in infancy might lead to more obvious symptoms in children with a 'flat mucosa' who otherwise may have remained undiagnosed. If that is the case, children born in Sweden after 1982-3 would be at less risk of diffuse and prolonged morbidity, which is typical of coeliac disease undiagnosed until adulthood.31 The concomitant risk of malignancies may thus also be avoided.32 The high prevalence of 'silent' coeliac disease among Swedish blood donors,33 close to the present cumulative incidence among Swedish children, might support this hypothesis.
On the other hand, the higher ingestion of wheat protein during infancy might lead to the clinical expression of coeliac disease and development of a flat mucosa in a group of people with genetic susceptibility for the disease who, on lower exposure, may remain completely healthy with a normal or almost normal intestinal mucosa. The answer to this question, however, lies beyond the scope of this study. 7 after the antithymocyte serum was also reduced if the rats had been given decorin for four or six days. Urine protein to creatinine ratios were 0-7 in normal rats, 15-2 in glomerulonephritic rats given no decorin, 14'8 in those given decorin for two days, and 2 4 in those given it for four or six days (p=0-01 for four or six days decorin compared with no decorin).
Radiolabelled decorin given intravenously accumulates in the kidneys, liver and lungs and the authors suggest, therefore, that it may prove useful in the treatment of proliferative diseases in these three organs. The different isoforms of TGF-p may be implicated in different diseases, for instance TGF-pl is raised in glomerulonephritis and TGF-P2 in the eye in proliferative vitreoretinopathy and in the skin in systemic sclerosis. The availability of human recombinant decorin should make problems with immunogenicity less likely.
Clearly, from rat to human disease is a large step and the possibility of undesired effects especially in growing and developing organs must be explored but perhaps we can hope that work along these lines may point towards treatment of hitherto untreatable diseases.
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